Generic Drugs
-
{
- All
- News
- Videos
-
India Remains Critical Drug Supplier To US As It Seeks Pharma Self-Reliance: Report
India's vast pharmaceutical manufacturing network has emerged as a critical pillar of the US healthcare system, highlighting the challenges facing American President Donald Trump's efforts to bring generic drug production back to the United States, according to a report.
-
Supreme Court Flags Massive Gap Between Medicine MRP And Retailer Cost, Asks Government, "Allowing This To Happen?"
The Court was hearing a public interest litigation (PIL) filed by advocate Kishan Chand Jain seeking mandatory generic drug prescriptions, strict initial price controls on non-scheduled medicines, and statutory margin caps on medical devices under the Drug Price Control Order (DPCO).
-
India Supplies 30% Of Global Generic Drugs: What You Should Know
India supplies nearly thirty percent of the worlds generic medicines and aims to boost domestic use to reduce patients out-of-pocket costs.
-
Trump Announces Upto 200% Tariffs On Generic Drugs, Move May Impact India
India is often called the "pharmacy of the world" as it supplies generic medicines to countries across the globe. In the US, Indian generic medicines make up nearly 40 per cent by volume.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Pharma Players To Counter US Tariff Pain? THIS D-Street Expert Has A Plan: 'Diversify Away From...'
Amit Varma, Managing Partner, Quadria Capital believes that despite the short-term US tariff-sword, the outlook for India's pharma sector is positive.
-
Strides Pharma Gets FDA Nod For Generic Antidepressant Fluoxetine 60 Mg Tablet
The Bengaluru-based generic drugmaker will manufacture Fluoxetine tablets at a facility in Puducherry.
-
Sun Pharma Says 2018 Sales May Fall As U.S. Market Gets Tougher
The U.S. generics industry is facing rapidly changing market dynamics, Sun Pharma said
-
Strides to Take Control of Bafna's India Branded Generics Buisness
Drug firm Strides Arcolab will acquire a majority stake in the India-branded generics business of Bafna Pharmaceuticals for a cash consideration of Rs 48.1 crore.
-
Mandatory Prescription Of Generic Drugs Rule Put On Hold By Medical Panel
The National Medical Commission (NMC) on Thursday put on hold the regulations that make it mandatory for doctors to prescribe generic drugs and bar them from accepting gifts from pharma companies or endorsing any drug brands.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
Doctors To Be Penalised For Failing To Prescribe Generic Drugs, Say Rules
All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission.
.jpg 2.jpg?downsize=260:146 "Strides Pharma Gets FDA Nod For Generic Antidepressant Fluoxetine 60 Mg Tablet")
-
India Remains Critical Drug Supplier To US As It Seeks Pharma Self-Reliance: Report
India's vast pharmaceutical manufacturing network has emerged as a critical pillar of the US healthcare system, highlighting the challenges facing American President Donald Trump's efforts to bring generic drug production back to the United States, according to a report.
-
Supreme Court Flags Massive Gap Between Medicine MRP And Retailer Cost, Asks Government, "Allowing This To Happen?"
The Court was hearing a public interest litigation (PIL) filed by advocate Kishan Chand Jain seeking mandatory generic drug prescriptions, strict initial price controls on non-scheduled medicines, and statutory margin caps on medical devices under the Drug Price Control Order (DPCO).
-
India Supplies 30% Of Global Generic Drugs: What You Should Know
India supplies nearly thirty percent of the worlds generic medicines and aims to boost domestic use to reduce patients out-of-pocket costs.
-
Trump Announces Upto 200% Tariffs On Generic Drugs, Move May Impact India
India is often called the "pharmacy of the world" as it supplies generic medicines to countries across the globe. In the US, Indian generic medicines make up nearly 40 per cent by volume.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Pharma Players To Counter US Tariff Pain? THIS D-Street Expert Has A Plan: 'Diversify Away From...'
Amit Varma, Managing Partner, Quadria Capital believes that despite the short-term US tariff-sword, the outlook for India's pharma sector is positive.
-
Strides Pharma Gets FDA Nod For Generic Antidepressant Fluoxetine 60 Mg Tablet
The Bengaluru-based generic drugmaker will manufacture Fluoxetine tablets at a facility in Puducherry.
-
Sun Pharma Says 2018 Sales May Fall As U.S. Market Gets Tougher
The U.S. generics industry is facing rapidly changing market dynamics, Sun Pharma said
-
Strides to Take Control of Bafna's India Branded Generics Buisness
Drug firm Strides Arcolab will acquire a majority stake in the India-branded generics business of Bafna Pharmaceuticals for a cash consideration of Rs 48.1 crore.
-
Mandatory Prescription Of Generic Drugs Rule Put On Hold By Medical Panel
The National Medical Commission (NMC) on Thursday put on hold the regulations that make it mandatory for doctors to prescribe generic drugs and bar them from accepting gifts from pharma companies or endorsing any drug brands.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
Doctors To Be Penalised For Failing To Prescribe Generic Drugs, Say Rules
All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission.
